Sign In
Buy CTLT
$63.49
+0 (+0%)
At Close: Mar 14, 2025
KeyBanc Upgrades Catalent On Industry Transformation
10:30am, Thursday, 10'th Dec 2020
Catalent Inc (NYSE: CTLT) is a “key component” of the transformation of the health care industry from pharma to biopharma, according to KeyBanc Capital Markets. The Catalent Analyst: Paul Knight u
Looking for a Growth Stock? Why It is Time to Focus on Catalent (CTLT)
08:30am, Friday, 27'th Nov 2020
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Catalent (CTLT).
Final Trades: Deere, Host Hotels, Retail & more
01:22pm, Friday, 13'th Nov 2020
The "Halftime Report" traders give their top picks to watch for the second half.
Catalent Could Be A Big COVID-19 Vaccine Play: The Thing Behind The Thing
08:15am, Friday, 06'th Nov 2020
Each week, Benzinga will examine a stock that might be considered a little under the radar. You may have never heard of the company before, but chances are you're pretty familiar with the line of work
Catalent, Inc. (CTLT) CEO John Chiminski on Q1 2021 Results - Earnings Call Transcript
03:41pm, Tuesday, 03'rd Nov 2020
Catalent, Inc. (CTLT) CEO John Chiminski on Q1 2021 Results - Earnings Call Transcript
Catalent, Inc. Announces First Quarter Fiscal Year 2021 Earnings Conference Webcast
12:00am, Friday, 16'th Oct 2020
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biolog
Cell Line Development Services Market, 2028 - ResearchAndMarkets.com
12:00am, Monday, 12'th Oct 2020
The
Coronavirus updates: U.S. cases top 7 million; Florida lifts restaurant restrictions
12:22pm, Friday, 25'th Sep 2020
The coronavirus has infected more than 32.36 million people globally as of Friday, killing at least 983,751 people so far.
The Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market will grow by USD 69.09 bn during 2020-2024
WHO says over 170 nations join Covid-19 vaccine distribution plan
01:21pm, Thursday, 17'th Sep 2020$3.71 Bn Vaccine Contract Manufacturing Market - Global Forecast to 2025 with Cumulative Impact of COVID-19 - ResearchAndMarkets.com
12:00am, Wednesday, 16'th Sep 2020
The
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2020 Update
10:49am, Friday, 11'th Sep 2020
Halvorsen's 13F portfolio value increased from $19.21B to $23.14B. The number of positions increased from 64 to 71.
Catalent, Inc. 2020 Q2 - Results - Earnings Call Presentation
09:25am, Wednesday, 02'nd Sep 2020
The following slide deck was published by Catalent, Inc. in conjunction with their 2020 Q2 earnings call..
Catalent, Inc. (CTLT) CEO John Chiminski on Q4 2020 Results - Earnings Call Transcript
04:25pm, Monday, 31'st Aug 2020
Catalent, Inc. (NYSE:CTLT) Q4 2020 Earnings Conference Call August 31, 2020 08:15 ET Company Participants Paul Surdez - Vice President, Investor Relations John Chiminski - Chair and Chief Executive Of
